BCP Partnering Portal / Beijing Microread Genetics Co Ltd
Microread is a company that specializes in genetic testing and diagnosis, focusing on multi-gene detection and providing overall solutions for genetic testing. The company's core products include DNA extraction kits, PCR instruments, and genetic analysis software, as well as DNA identification systems that can detect various numbers of STR (Short Tandem Repeat) loci. These products are used in applications such as prenatal diagnosis, where STR detection can help identify chromosomal abnormalities and genetic disorders. Microread's products and services are designed to support genetic testing and diagnosis in a range of fields, including forensic science, clinical research, and healthcare.
Microread Genetics Co., Ltd. (hereinafter called Microread Genetics) was founded on Dec. 2007, focusing on the commercialization of sequencing technology. We have developed a serise of accurate, rapid, easy-to-use and afforadable testing kits for forensic, clinical, agriculture and research proposes based on our sequencing platforms, through high-quality production process and quality control.
Microread Genetics is headquartered in Zhongguangcun Science and Technology Park, Haidian District, Beijing. Two GMP factories equipped with advanced facilities are based in Beijing and Suzhou, with a total area of over 3,000 square meters. They are capable of producing Class I, II, and III in vitro diagnostic reagents as well as products for forensic usage with an annual production capacity of 5 million tests, making us one of the top manufactory in this industry.
Microread Genetics have obtained various certifications, like national high-tech enterprise, national public safety product and ISO quality management system certifications. We also obtained Class III medical device production license and owned a independent third-party clinical laboratory, with dozens of invention patents and software copyrights.
Microread Genetics has received multuple national, provincial and municipal project fundings. At present, it has nearly 300 employees and the annual gross income is over 100 million CNY.
Forensics Science
■ Evidence preservation
■ DNA extration
■ DNA amplification
Clinical Molecular Diagnostics
■ Reproductive
■ Cardiovascular
■ Cancer
Technology Platform
■ Easy-to-use
■ Accurate
■ Affordable
■ Wide applications
2007
Where Manufacturers and Channel Partners / Distributors find each other!